Insider buying
~$54K3,000 sh @ $18.00
Traded Sep 27, 2024 · filed 164 days later
A Bioage Labs director paid $54K out of pocket for Bioage Labs shares. 3 other people at Bioage Labs bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BIOA · NASDAQ · Pharmaceutical Preparations
Bioage Labs (BIOA) · oqro.io/stocks/BIOA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$4.28−0.43 (−9.13%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Insider buying
Traded Sep 27, 2024 · filed 164 days later
A Bioage Labs director paid $54K out of pocket for Bioage Labs shares. 3 other people at Bioage Labs bought some too, in the same month.
Insider buying
Traded Sep 27, 2024 · filed 164 days later
Bioage Labs's Principal Accounting Officer paid $47K out of pocket for Bioage Labs shares. 3 other people at Bioage Labs bought some too, in the same month.
Traded Oct 1 – Oct 3, 2024 · largest single transaction ~$2.5M
Oct 1, 2024~$2.5M · 127K sh @ $19.73
DetailsOfficial recordInsider buying
Traded Sep 27, 2024 · filed 4 days later
Bioage Labs's LP, Reporting person paid $8.1M out of pocket for Bioage Labs shares. 3 other people at Bioage Labs bought some too, in the same month. Shares held went up 38% with this purchase.
Oct 2, 2024~$1.32M · 67K sh @ $19.73
DetailsOfficial recordOct 3, 2024~$504K · 25K sh @ $19.90
DetailsOfficial record0 open-market purchases and 0 open-market sales by insiders of BIOA between Feb 22, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 5, 2026. The data provider lists the next release for Nov 25, 2026; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 5, 2026 | None | None | None |
| Aug 5, 2026 | None | None | None |
| May 8, 2026 | None | None | None |
| Mar 24, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies